These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 38990048)
1. Hormone replacement therapy and myocardial infarction and stroke in postmenopausal Korean women. Baek JK; Kim HY; Kang MJ; Choi EA; Lee JK; Kim EH; Seo SK Climacteric; 2024 Aug; 27(4):406-412. PubMed ID: 38990048 [TBL] [Abstract][Full Text] [Related]
2. Effect of menopausal hormonal therapy on cardiovascular risks in Korean postmenopausal women: A nationwide cohort study. Yuk JS; Kim GS; Byun YS; Yang SW; Kim MH; Yoon SH; Seo YS; Kim BG BJOG; 2024 Aug; 131(9):1306-1317. PubMed ID: 38465460 [TBL] [Abstract][Full Text] [Related]
3. Relationship between the type of hormone replacement therapy and incidence of breast cancer in Korea. Baek JK; Kim HI; Kang MJ; Seon KE; Kim EH; Seo SK Climacteric; 2022 Oct; 25(5):516-522. PubMed ID: 35674251 [TBL] [Abstract][Full Text] [Related]
4. Hormone replacement therapy, prothrombotic mutations, and the risk of incident nonfatal myocardial infarction in postmenopausal women. Psaty BM; Smith NL; Lemaitre RN; Vos HL; Heckbert SR; LaCroix AZ; Rosendaal FR JAMA; 2001 Feb; 285(7):906-13. PubMed ID: 11180734 [TBL] [Abstract][Full Text] [Related]
5. Is breast cancer risk the same for all progestogens? Stute P Arch Gynecol Obstet; 2014 Aug; 290(2):207-9. PubMed ID: 24838289 [TBL] [Abstract][Full Text] [Related]
6. Hormone therapy and the risk of stroke after acute myocardial infarction in postmenopausal women. Angeja BG; Shlipak MG; Go AS; Johnston SC; Frederick PD; Canto JG; Barron HV; Grady D; J Am Coll Cardiol; 2001 Nov; 38(5):1297-301. PubMed ID: 11691498 [TBL] [Abstract][Full Text] [Related]
7. Relationship between menopausal hormone therapy and incidence of fractures in postmenopausal women. Kim H; Kang MJ; Baek JK; Lee JK; Choi EA; Yun BH; Kim EH; Seo SK Climacteric; 2024 Apr; 27(2):165-170. PubMed ID: 37947171 [TBL] [Abstract][Full Text] [Related]
8. Myocardial infarction risk and hormone replacement: differences between products. de Vries CS; Bromley SE; Farmer RD Maturitas; 2006 Feb; 53(3):343-50. PubMed ID: 16040209 [TBL] [Abstract][Full Text] [Related]
9. Use and discontinuation of hormone replacement therapy in women with myocardial infarction: a nationwide study. Bretler DM; Hansen PR; Abildstrøm SZ; Jørgensen CH; Sørensen R; Hansen ML; Schramm TK; Løkkegaard E; Torp-Pedersen C; Gislason GH Br J Clin Pharmacol; 2011 Jan; 71(1):105-15. PubMed ID: 21143506 [TBL] [Abstract][Full Text] [Related]
10. Postmenopausal hormone use in women with acute coronary syndromes. Parsons E; Newby LK; Bhapkar MV; Alexander KP; White HD; Shah SH; Bushnell CD; Califf RM; J Womens Health (Larchmt); 2004 Oct; 13(8):863-71. PubMed ID: 15671702 [TBL] [Abstract][Full Text] [Related]
11. A 5-year study on the effect of hormone therapy, tibolone and raloxifene on vaginal bleeding and endometrial thickness. Christodoulakos GE; Botsis DS; Lambrinoudaki IV; Papagianni VD; Panoulis CP; Creatsa MG; Alexandrou AP; Augoulea AD; Dendrinos SG; Creatsas GC Maturitas; 2006 Mar; 53(4):413-23. PubMed ID: 16140483 [TBL] [Abstract][Full Text] [Related]
12. Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study. Renoux C; Dell'aniello S; Garbe E; Suissa S BMJ; 2010 Jun; 340():c2519. PubMed ID: 20525678 [TBL] [Abstract][Full Text] [Related]
13. Hormone therapy administration in postmenopausal women and risk of stroke. Renoux C; Suissa S Womens Health (Lond); 2011 May; 7(3):355-61. PubMed ID: 21612355 [TBL] [Abstract][Full Text] [Related]
14. The effect of hormone replacement therapy and tibolone on lipoprotein (a) concentrations in postmenopausal women: A systematic review and meta-analysis. Anagnostis P; Galanis P; Chatzistergiou V; Stevenson JC; Godsland IF; Lambrinoudaki I; Theodorou M; Goulis DG Maturitas; 2017 May; 99():27-36. PubMed ID: 28364865 [TBL] [Abstract][Full Text] [Related]
15. Relationship between menopausal hormone therapy and colorectal cancer: a cohort study utilizing the health insurance database in South Korea (HISK)-II. Yuk JS; Noh JH; Kim MH; Han GH; Kim J; Cho H; Gwak G; Lee Y Menopause; 2024 Aug; 31(8):686-692. PubMed ID: 38860931 [TBL] [Abstract][Full Text] [Related]
16. Suicidal ideation among postmenopausal women on hormone replacement therapy: The Korean National Health and Nutrition Examination Survey (KNHANES V) from 2010 to 2012. Lee JY; Park YK; Cho KH; Kim SM; Choi YS; Kim DH; Nam GE; Han KD; Kim YH J Affect Disord; 2016 Jan; 189():214-9. PubMed ID: 26451506 [TBL] [Abstract][Full Text] [Related]
17. Hormone replacement therapy use and the risk of stroke. Renoux C; Dell'aniello S; Garbe E; Suissa S Maturitas; 2008 Dec; 61(4):305-9. PubMed ID: 18996656 [TBL] [Abstract][Full Text] [Related]
18. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Beral V; Bull D; Reeves G; Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308 [TBL] [Abstract][Full Text] [Related]
19. Hormone therapy for preventing cardiovascular disease in post-menopausal women. Boardman HM; Hartley L; Eisinga A; Main C; Roqué i Figuls M; Bonfill Cosp X; Gabriel Sanchez R; Knight B Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD002229. PubMed ID: 25754617 [TBL] [Abstract][Full Text] [Related]
20. The use of hormonal replacement therapy and the risk of stroke and myocardial infarction in women. Thompson SG; Meade TW; Greenberg G J Epidemiol Community Health; 1989 Jun; 43(2):173-8. PubMed ID: 2592907 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]